We are live on ! Find out more
Assenagon Asset Management

Assenagon Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 50.57%
This Fund
S&P 500
This Quarter Est. Return
+15.23%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
AUM
$42.2B
AUM Growth
+$4.57B
Cap. Flow
+$366M
Cap. Flow %
0.87%
Top 10 Hldgs %
34.77%
Holding
1,523
New
131
Increased
531
Reduced
620
Closed
173

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$662M
2
AMZN icon
Amazon
AMZN
+$616M
3
AMD icon
Advanced Micro Devices
AMD
+$412M
4
ISRG icon
Intuitive Surgical
ISRG
+$256M
5
AVGO icon
Broadcom
AVGO
+$232M

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Consumer Discretionary 14%
3 Healthcare 11.18%
4 Communication Services 10.66%
5 Financials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARA
1326
DELISTED
Paramount Global Class B
PARA
$222K ﹤0.01%
18,858
+1,754
+10% +$22.1K
IMAX icon
1327
IMAX
IMAX
$2.81B
$222K ﹤0.01%
+13,726
New +$209K
EEX
1328
DELISTED
Emerald Holding
EEX
$221K ﹤0.01%
32,380
+5,785
+22% +$35.7K
TU icon
1329
Telus
TU
$15.1B
$218K ﹤0.01%
13,631
+892
+7% +$15.6K
SWK icon
1330
Stanley Black & Decker
SWK
$15.5B
$217K ﹤0.01%
2,217
-103,401
-98% -$9.53M
BBIO icon
1331
BridgeBio Pharma
BBIO
$16.6B
$216K ﹤0.01%
6,995
-29,739
-81% -$1.01M
EG icon
1332
Everest Group
EG
$14.2B
$201K ﹤0.01%
506
-4,772
-90% -$1.79M
FFWM
1333
DELISTED
First Foundation Inc
FFWM
$171K ﹤0.01%
+22,602
New +$193K
HUN icon
1334
Huntsman Corp
HUN
$1.82B
$160K ﹤0.01%
+6,146
New +$153K
TVRD
1335
Tvardi Therapeutics
TVRD
$22M
$158K ﹤0.01%
4,815
+153
+3% +$3.97K
XPER icon
1336
Xperi
XPER
$332M
$154K ﹤0.01%
12,756
-1,075,640
-99% -$11.8M
ARC
1337
DELISTED
ARC Document Solutions, Inc.
ARC
$147K ﹤0.01%
53,125
+16,167
+44% +$45.7K
CRBU icon
1338
Caribou Biosciences
CRBU
$165M
$137K ﹤0.01%
26,592
-2,231,947
-99% -$13.8M
UFI icon
1339
UNIFI
UFI
$129M
$135K ﹤0.01%
22,532
-30,718
-58% -$186K
IMMR icon
1340
Immersion
IMMR
$257M
$134K ﹤0.01%
+17,900
New +$127K
OPTN
1341
DELISTED
OptiNose
OPTN
$127K ﹤0.01%
5,806
+3,377
+139% +$75K
LFCR icon
1342
Lifecore Biomedical
LFCR
$176M
$127K ﹤0.01%
23,852
EGHT icon
1343
8x8 Inc
EGHT
$324M
$124K ﹤0.01%
45,990
PMVP icon
1344
PMV Pharmaceuticals
PMVP
$65.6M
$120K ﹤0.01%
70,814
SCPH
1345
DELISTED
scPharmaceuticals
SCPH
$99.5K ﹤0.01%
+19,822
New +$111K
AIRG icon
1346
Airgain
AIRG
$71.7M
$82.6K ﹤0.01%
15,150
-6,430
-30% -$27.3K
MAGN
1347
Magnera Corp
MAGN
$466M
$66.8K ﹤0.01%
2,567
-34,023
-93% -$807K
CULP icon
1348
Culp Inc
CULP
$42.7M
$57.1K ﹤0.01%
11,889
-740
-6% -$3.71K
ORMP icon
1349
Oramed Pharmaceuticals
ORMP
$175M
$54.5K ﹤0.01%
+18,659
New +$52.2K
ENZ
1350
DELISTED
Enzo Biochem, Inc.
ENZ
$25.1K ﹤0.01%
19,773
-52,643
-73% -$69.5K

Similar funds

Assenagon Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Assenagon Asset Management held 1,523 positions worth $42.2B, up 12% from $37.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Assenagon Asset Management's Q1 2024 filing shows 131 new, 531 increased, 620 reduced and 173 closed positions. Its largest new stake was Federated Hermes: 817,234 shares worth $29.5M. The largest sale was Procter & Gamble, an estimated $344M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Assenagon Asset Management's largest Q1 2024 buy was Federated Hermes: 817,234 shares worth $29.5M.
  • Assenagon Asset Management added most to Pinduoduo in Q1 2024, an estimated $662M increase.
  • Assenagon Asset Management's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $344M.
  • Assenagon Asset Management fully exited FIVE9 in Q1 2024, selling an estimated $65.9M.
  • Assenagon Asset Management's ten largest holdings make up 35% of its $42.2B portfolio in Q1 2024.
  • Assenagon Asset Management opened 131 new positions and closed 173 in Q1 2024.
  • Assenagon Asset Management's portfolio value rose 12% quarter-over-quarter to $42.2B.

Based on Assenagon Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.